Recent Research Analysts’ Ratings Changes for Merit Medical Systems (MMSI)

A number of firms have modified their ratings and price targets on shares of Merit Medical Systems (NASDAQ: MMSI) recently:

• 10/30/2026 – Merit Medical Systems had its price target raised by Canaccord Genuity Group from $94.00 to $121.00. They now have a “buy” rating on the stock.
• 10/30/2026 – Merit Medical Systems had its price target raised by Needham & Company LLC from $101.00 to $106.00. They now have a “buy” rating on the stock.
• 10/30/2026 – Merit Medical Systems had its price target raised by JPMorgan Chase & Co. from $95.00 to $110.00. They now have an “overweight” rating on the stock.
• 10/30/2026 – Merit Medical Systems had its price target raised by Wells Fargo & Company from $83.00 to $92.00. They now have an “equal weight” rating on the stock.
• 10/30/2026 – Merit Medical Systems had its price target raised by BTIG Research from $105.00 to $110.00. They now have a “buy” rating on the stock.
• 10/27/2026 – Merit Medical Systems is now covered by Freedom Capital. They set a “hold” rating on the stock.
• 10/19/2026 – Merit Medical Systems was downgraded by Zacks Research from “strong-buy” to “hold”.
• 10/12/2026 – Merit Medical Systems was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 9/29/2026 – Merit Medical Systems had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $101.00 price target on the stock.

Merit Medical Systems Trading Down 2.2%

Shares of MMSI stock traded down $1.93 during trading hours on Monday, reaching $84.31. The company’s stock had a trading volume of 1,203,763 shares, compared to its average volume of 795,252. The stock has a market capitalization of $5.03 billion, a P/E ratio of 31.70, a P/E/G ratio of 2.15 and a beta of 0.51. Merit Medical Systems, Inc. has a one year low of $59.74 and a one year high of $94.85. The firm’s fifty day simple moving average is $88.60 and its 200 day simple moving average is $77.14. The company has a current ratio of 4.52, a quick ratio of 3.05 and a debt-to-equity ratio of 0.42.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.08. Merit Medical Systems had a return on equity of 14.12% and a net margin of 9.94%. The company had revenue of $416.24 million during the quarter, compared to the consensus estimate of $410.56 million. During the same quarter in the prior year, the company earned $0.92 earnings per share. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. Equities research analysts expect that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.